A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle(®) for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation

CONTEXT: A new indigenous recombinant human chorionic gonadotropin (r-hCG) has been developed in India with a comparable pharmacological profile to that of Ovitrelle(®) (Merck Serono). AIMS: This study aims to compare the efficacy and safety of the new r-hCG with that of Ovitrelle for induction of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumdar, Abha, Sachan, Rekha, Nandanwar, Yogeshwar S., Mayekar, Rahul V., Soni, Neelu, Banker, Manish R., Vaidya, Rajan S., Arora, Manjeet, Godbole, Girish P., Daftary, Gautam V., Divekar, Ganesh H., John, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472201/
https://www.ncbi.nlm.nih.gov/pubmed/31007468
http://dx.doi.org/10.4103/jhrs.JHRS_101_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472201/
https://www.ncbi.nlm.nih.gov/pubmed/31007468
http://dx.doi.org/10.4103/jhrs.JHRS_101_18

Ejemplares similares